Delivering on the promise of personalized healthcare

Personalized Medicine
Ruth March

Abstract

Personalized healthcare (PHC) aims to deliver the right medicine, to the right patient, at the right dose and time, and has the potential to benefit everyone in the healthcare system. Delivering the promise of PHC depends on overcoming key challenges (e.g., identifying biomarkers or disease segmentation tools, facilitating partnerships, clinical development, regulatory engagement and market access) in an integrated fashion. Despite this, progress in PHC has been accelerating over the last few years and is now at a turning point. Flexibility from all those involved in PHC, including the pharmaceutical and diagnostic industries, health authorities and payers, will be required to ensure that the field comes to maturity and delivers its potential to improve patients' lives.

References

Dec 30, 1994·Biochimica Et Biophysica Acta·N E Hynes, D F Stern
Mar 10, 2001·Clinical Pharmacology and Therapeutics·UNKNOWN Biomarkers Definitions Working Group.
May 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Masahiro FukuokaJosé Baselga
May 21, 2003·Annals of Internal Medicine·Razelle KurzrockMoshe Talpaz
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Philip D BonomiJohn Coon
Dec 12, 2007·Handbook of Experimental Pharmacology·H M ShepardD C Maneval
May 10, 2008·Nature Biotechnology·Malorye Allison
Oct 14, 2008·Experimental Biology and Medicine·Randal J KirkJeffrey T Perez
Oct 14, 2008·Experimental Biology and Medicine·Mary K Pendergast
Dec 9, 2008·Clinics in Laboratory Medicine·Charles E Hill, Alexander Duncan
Dec 24, 2008·Pharmacogenomics·Robert S EpsteinBenjamin Zelman
Jan 7, 2009·Genetics in Medicine : Official Journal of the American College of Medical Genetics·UNKNOWN Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
Mar 31, 2009·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Mey WangGuei-Feng Tsai
Mar 21, 2009·Nature Reviews. Drug Discovery·Jerel C DavisPhilip Ma
Apr 9, 2009·Molecular Diagnosis & Therapy·Elizabeth Phillips, Simon Mallal
Apr 23, 2009·Journal of Biopharmaceutical Statistics·Sumithra J Mandrekar, Daniel J Sargent
Jul 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sumithra J Mandrekar, Daniel J Sargent
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
May 1, 2006·Personalized Medicine·Ruth March

❮ Previous
Next ❯

Citations

Nov 1, 2010·Personalized Medicine·Hsin-Lu ChangChin-Chung Shu
Jan 1, 2013·Journal of Personalized Medicine·Julius Alexander Steffen, Jan Simon Steffen

❮ Previous
Next ❯

Methods Mentioned

BETA
PMA

Software Mentioned

MammaPrint

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
S Sendyona
New Zealand Hospital
D Patston
© 2022 Meta ULC. All rights reserved